Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1
Aging · 2024
DOI: 10.18632/aging.205882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Wenhuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuh…. Hauptthemen laut MEDLINE: Sirtuin 1, Cellular Senescence, Quinolines, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
Zitieren
APA
Li, W., Fu, P., Shi, P., Hu, B., & Li, H. (2024). Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1. Aging. https://doi.org/10.18632/aging.205882
Vancouver
Li W, Fu P, Shi P, Hu B, Li H. Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1. Aging. 2024. doi:10.18632/aging.205882
BibTeX
@article{Li2024,
author = {Li, Wenhuan and Fu, Peng and Shi, Pengfei and Hu, Bo and Li, Hai},
title = {Neratinib stimulates senescence of mammary cancer cells by reducing the levels of SIRT1},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205882}
}
EUVIMED